Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Rangering i aksjer #19086
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Aksjekurs
$10.18
Sist synkronisert: 2023-03-01
Markedsverdi
$175.61M
Endring (1 dag)
-0.29%
Endring (1 år)
0.00%
Land
US
Handel Ibere Pharmaceuticals (IBER)
P/B-forhold for Ibere Pharmaceuticals (IBER)
P/B-forhold per 2026 TTM: 0
Ifølge Ibere Pharmaceuticals sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Ibere Pharmaceuticals fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter